Send to a Friend Share

FTN Midwest Downgrades Barrier Therapeutics (BTRX) to Neutral

August 6, 2008 11:59 AM EDT
BTRX Hot Sheet
Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 1
FTN Midwest downgrades Barrier Therapeutics (Nasdaq: BTRX) from Buy to Neutral.

Barrier Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the field of dermatology in the United States.

You May Also Be Interested In


Related Categories

Downgrades

Related Entities

FTN Midwest

Add Your Comment





Follow StreetInsider.com On Twitter